Ye, C., Hou, W., Chen, M., Lu, J., Chen, E., Tang, L., . . . He, R. (2019). IGFBP7 acts as a negative regulator of RANKL‐induced osteoclastogenesis and oestrogen deficiency‐induced bone loss. Cell Prolif.
Chicago-stil citatYe, Chenyi, et al. "IGFBP7 Acts As a Negative Regulator of RANKL‐induced Osteoclastogenesis and Oestrogen Deficiency‐induced Bone Loss." Cell Prolif 2019.
MLA-referensYe, Chenyi, et al. "IGFBP7 Acts As a Negative Regulator of RANKL‐induced Osteoclastogenesis and Oestrogen Deficiency‐induced Bone Loss." Cell Prolif 2019.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.